Co-founder of ShiftBio, Professor In-san Kim received ''The 1st Lim Sungki Researcher Award 2022'' !

28 Dec 2021

Prof. Dr. In-san Kim, the co-founder of ShiftBio received the 1st Lim Seong-ki Researcher Award. The Lim Seong-ki Researcher Award was established to commemorate the philosophy of new drug development of the late Chairman Lim Seong-ki, the founder of Hanmi Pharmaceutical Group, and awarded to researchers who have made outstanding achievements in the fields of biotechnology and pharmaceuticals countrywide.

The Lim Seong-ki Researcher Award is the best biotechnology and pharmaceutical award in Korea established by Hanmi Pharmaceutical Group, Lim Seong-ki Foundation founded by the family of Chairman Lim as the top priority to inherit Chairman Lim' s commitment to new drug development after his death. The foundation formed a judging committee comprised of scholars from medicine, pharmacy, and life sciences and selected the winners through rigorous screening three times over the past three months.

It is of great importance as it is an award given to the most successful researcher studying the new drug development in the country. It is an incredible honor for the ShiftBio family, and once again we sincerely congratulate our co-founder, Prof. In-San Kim for his astonishing achievement.  

              Co-founder of ShiftBio,  In-San Kim MD, Ph.D. is receiving his award.

Some of the related news on the Korean media: